TG Therapeutics, Inc. (MHA) Announces Third Quarter 2012 Financial Results and Business Update  
11/9/2012 10:00:51 AM

NEW YORK, Nov. 8, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced its results for the third quarter ended September 30, 2012 and recent company developments.